Biosynthesis of the receptor for epidermal growth factor was investigated in two human tumor-derived cell lines, Hep 3B and A431. When grown in the presence of tunicamycin, both cells expressed a receptor-related species p135, the presumptive aglycosylated form of the biosynthetic precursor, gp145, of the mature form of the receptor, gp165, expressed at the cell surface. Two additional receptor-related species, p15 and p70, were detected when A431, but not Hep 3B, cells were treated with tunicamycin. Furthermore, digestion of the A431 receptor-related proteins with endoglycosidase F resulted in the detection of these three aglycosylated species. P70 appears to be the aglycosylated form of gp95, the presumptive intracellular precursor of the receptorrelated species gpl20 that is secreted by A431 but not Hep 3B cells; gpl20 has a complex pattern of N-linked glycosylation, with consequent molecular weight and charge heterogeneity. P115 may be the aglycosylated form of a third biosynthetic intermediate, possibly a gp135 species detected in the early time points of pulse-chase labeling. Alternatively, p115 and gp135 may be derived co-or post-translationally by Ca2+-mediated proteolysis from p135 and gp145, respectively. The implications of the complexity of the biosynthesis of this molecule with regard to the multiple opportunities it affords the cell to modulate cell proliferation are discussed.Epidermal growth factor (EGF) enhances epidermal cell growth and keratinization in vivo (9) and proliferation of meso-and ectodermally derived cells in vitro (8, 23). The mitogenic response of cells to EGF is triggered by its binding to specific cellular receptors, which are subsequently internalized (8) and at least partially degraded in lysosomes (12). Whether cleavage of the C terminus of the EGF receptor by an apparently ubiquitous Ca2+-dependent protease has some function, for example that of generating a second messenger, in relaying the mitogenic signal remains an intriguing if unresolved question (19,58). The EGF receptor is also a tyrosine-specific protein kinase (53), as are at least three other hormone receptors (15,26,45) and several of the transforming proteins encoded by RNA tumor viruses of the Rous sarcoma gene family (2,4,10,24,32,41,44,54,57). This suggests that phosphorylation of tyrosine may underlie a more general mechanism of growth control. The link between proteins that regulate normal growth and cellular transformation is further strengthened by recent findings of sequence homology between virally encoded proteins and growth factor-related molecules. The v-erb B protein of avian erythroblastosis virus, for example, shares extensive homology with a portion of the EGF receptor that includes the ATP-binding site of the presumptive kinase domain (3,14).It is now clear that growth factors and growth factorrelated molecules also play a role during early embryonic development. Several groups have detected growth factors or growth factor receptors in mammalian fetal tissue (38, 42), and we have recently demon...